Joseph Douglas Mancias, M.D., Ph.D.
This page shows the publications co-authored by Joseph Mancias and Miljan Kuljanin.
Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries. Nat Biotechnol. 2021 May; 39(5):630-641.
Defining and Targeting Adaptations to Oncogenic KRASG12C Inhibition Using Quantitative Temporal Proteomics. Cell Rep. 2020 03 31; 30(13):4584-4599.e4.
Selective modulation of a pan-essential protein as a therapeutic strategy in cancer. Cancer Discov. 2021 Apr 21.
Neurons Release Serine to Support mRNA Translation in Pancreatic Cancer. Cell. 2020 11 25; 183(5):1202-1218.e25.
Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules. Nat Commun. 2020 09 18; 11(1):4687.
Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing. Cell Chem Biol. 2020 10 15; 27(10):1229-1240.e4.
Discovery of a selective inhibitor of doublecortin like kinase 1. Nat Chem Biol. 2020 06; 16(6):635-643.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.